Mir Imran

From Wikipedia, the free encyclopedia

Mir Imran is a prolific entrepreneur and venture capitalist, with a long track record of success in medical technology. As an inventor, Mir holds over 200 issued patents, and is well known for his pioneering role in creating the first implantable defibrillator (Intec Systems, alongside Michael Mirowski), the first EEG monitor, the Trans-Urethral Needle Ablation (TUNA) procedure, embolic protection devices, and an ultrasound imaging device.

As an entrepreneur, Mir has founded over 20 medical device companies, including: Vidamed (acquired by Medtronic), Physiometrix (IPO 1996), Cardiac Pathways (IPO 1996), Advanced Cytomextrix (acquired by Oncotech 1997), Percusurge (acquired by Medtronic 2001), Reflow, Inc. (acquired 1999), Safeview (acquired by L3 2006) Intrapace ( founded 2001), Spinal Modulation (founded 2005) and Zonare (founded 1999).

As an investor, Mir serves as the Life Science Venture Partner for DFJ ePlanet, where he has led 9 investments in a range of promising ventures around the globe. In addition to his venture capital activities, Mir is an active angel investor, with a portfolio based around both medical and pharmaceutical ventures. Mir holds board seats with Bodymedia, Cardiovasc, Intrapace, Egeen International, Spinal Modulation, ZARS and Zonare.

Outside of the medical device industry, Mir is responsible for the electronic real estate lockbox, now sold by GE under the Supra brand, and was the co-founder of SafeView Inc., which commercialized 3d holographic technology for use in the Homeland Security market.

In addition to his venture capital activities, Mir Imran is currently the CEO of Incube Laboratories [1], where he develops and commercializes therapeutic medical devices. Mir received his BS in Electrical Engineering and MS in Biomedical Engineering from Rutgers University.